Literature DB >> 25795599

Hippocampal function is compromised in an animal model of multiple sclerosis.

T Novkovic1, O Shchyglo1, R Gold2, D Manahan-Vaughan3.   

Abstract

Multiple sclerosis (MS) is a progressive inflammatory autoimmune disease that is characterized by demyelination and axonal damage in the nervous system. One obvious consequence is a cumulative loss of muscle control. However, cognitive dysfunction affects roughly half of MS sufferers, sometimes already early in the disease course. Although long-term (remote) memory is typically unaffected, the ability to form new declarative memories becomes compromised. A major structure for the encoding of new declarative memories is the hippocampus. Encoding is believed to be mediated by synaptic plasticity in the form of long-term potentiation (LTP) and long-term depression (LTD) of synaptic strength. Here, in an animal model of MS we explored whether disease symptoms are accompanied by a loss of functional neuronal integrity, synaptic plasticity, or hippocampus-dependent learning ability. In mice that developed MOG35-55-induced experimental autoimmune encephalomyelitis (EAE), passive properties of CA1 pyramidal neurons were unaffected, although the ability to fire action potentials became reduced in the late phase of EAE. LTP remained normal in the early phase of MOG35-55-induced EAE. However, in the late phase, LTP was impaired and LTP-related spatial memory was impaired. In contrast, LTD and hippocampus-dependent object recognition memory were unaffected. These data suggest that in an animal model of MS hippocampal function becomes compromised as the disease progresses.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EAE; LTD; LTP; inflammation; object recognition; spatial memory

Mesh:

Substances:

Year:  2015        PMID: 25795599     DOI: 10.1016/j.neuroscience.2015.03.008

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.

Authors:  Laura G Kammel; Weizheng Wei; Shekib A Jami; Rhonda R Voskuhl; Thomas J O'Dell
Journal:  Neuroscience       Date:  2018-11-14       Impact factor: 3.590

2.  Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.

Authors:  Andrew J Kwilasz; Laurel S Todd; Julissa C Duran-Malle; Anouk E W Schrama; Eric H Mitten; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Xiaohui Wang; Anne-Marie Van Dam; Steven F Maier; Kenner C Rice; Linda R Watkins; Ruth M Barrientos
Journal:  Behav Brain Res       Date:  2020-09-06       Impact factor: 3.332

3.  Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.

Authors:  Tommaso Bonfiglio; Guendalina Olivero; Elisa Merega; Silvia Di Prisco; Cristina Padolecchia; Massimo Grilli; Marco Milanese; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Giambattista Bonanno; Mario Marchi; Anna Pittaluga
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

4.  Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis.

Authors:  Jennetta W Hammond; Matthew J Bellizzi; Caroline Ware; Wen Q Qiu; Priyanka Saminathan; Herman Li; Shaopeiwen Luo; Stefanie A Ma; Yuanhao Li; Harris A Gelbard
Journal:  Brain Behav Immun       Date:  2020-03-06       Impact factor: 7.217

5.  Retinoic Acid Signaling: A New Piece in the Spoken Language Puzzle.

Authors:  Jon-Ruben van Rhijn; Sonja C Vernes
Journal:  Front Psychol       Date:  2015-11-26

6.  Thalamocortical-auditory network alterations following cuprizone-induced demyelination.

Authors:  Nikoo Ghaffarian; Masoud Mesgari; Manuela Cerina; Kerstin Göbel; Thomas Budde; Erwin-Josef Speckmann; Sven G Meuth; Ali Gorji
Journal:  J Neuroinflammation       Date:  2016-06-22       Impact factor: 8.322

7.  Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis.

Authors:  Massimiliano Di Filippo; Antonio de Iure; Carmela Giampà; Davide Chiasserini; Alessandro Tozzi; Pier Luigi Orvietani; Veronica Ghiglieri; Michela Tantucci; Valentina Durante; Ana Quiroga-Varela; Andrea Mancini; Cinzia Costa; Paola Sarchielli; Francesca Romana Fusco; Paolo Calabresi
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

Review 8.  Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation.

Authors:  Francesca Romana Rizzo; Alessandra Musella; Francesca De Vito; Diego Fresegna; Silvia Bullitta; Valentina Vanni; Livia Guadalupi; Mario Stampanoni Bassi; Fabio Buttari; Georgia Mandolesi; Diego Centonze; Antonietta Gentile
Journal:  Neural Plast       Date:  2018-05-14       Impact factor: 3.599

9.  The role of myelin damage in Alzheimer's disease pathology.

Authors:  Ewa Papuć; Konrad Rejdak
Journal:  Arch Med Sci       Date:  2018-08-28       Impact factor: 3.318

10.  Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.

Authors:  Baohua Hou; Yahui Zhang; Peiyu Liang; Yuan He; Biwen Peng; Wanhong Liu; Song Han; Jun Yin; Xiaohua He
Journal:  Cell Death Dis       Date:  2020-05-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.